Advanced Search

Study Preview



Study Title and Description

Attenuation of glycemic responses by oat ß-glucan solutions and viscoelastic gels is dependent on molecular weight distribution.



Key Questions Addressed
1 Is this a fiber intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Attenuation of glycemic responses by oat ß-glucan solutions and viscoelastic gels is dependent on molecular weight distribution.
Author Kwong MG., Wolever TM., Brummer Y., Tosh SM.
Country Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada.
Year 2013
Numbers Pubmed ID: 23187607

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber Database
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
Year of Publication 2013
  • Comments Comments (
    0
    ) |
Country of Publication Canada
  • Comments Comments (
    0
    ) |
What was the study design? Randomized Controlled Trial (Crossover)
  • Comments Comments (
    0
    ) |
Was the study blinded? unspecified
  • Comments Comments (
    0
    ) |
Study diet type acute feeding study
  • Comments Comments (
    0
    ) |
Level of feeding control for dietary intervention Food partially provided
  • Comments Comments (
    0
    ) |
Sample size 15
  • Comments Comments (
    0
    ) |
Is there a run-in period? No
  • Comments Comments (
    0
    ) |
Is there a washout period? No
  • Comments Comments (
    0
    ) |
Did the administered fiber dose change over the course of the study? No
  • Comments Comments (
    0
    ) |
What is the age of the population (categorical)? Adults (20+ Years)
  • Comments Comments (
    0
    ) |
Study population, mean age in years 37.2
  • Comments Comments (
    0
    ) |
Study population, age range in years -
  • Comments Comments (
    0
    ) |
Study Population, mean BMI, kg/m2 26.6
  • Comments Comments (
    0
    ) |
Study population, BMI Range, kg/m2 -
  • Comments Comments (
    0
    ) |
Baseline health status Healthy
  • Comments Comments (
    0
    ) |
Gender (% male) ~53.33
  • Comments Comments (
    0
    ) |
Fiber 1-type Beta-Glucans
  • Comments Comments (
    0
    ) |
Fiber 1-if combination was selected for fiber type, 1st fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 1-if combination was selected for fiber type, 2nd fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 1- dose 1 (g) 4.0
  • Comments Comments (
    0
    ) |
Fiber 1- dose 2 (g) -
  • Comments Comments (
    0
    ) |
Fiber 1-Duration of intervention 2 hours
  • Comments Comments (
    0
    ) |
Fiber 1-how was the fiber administered? Beverage
  • Comments Comments (
    0
    ) |
Fiber 2-type Beta-Glucans
  • Comments Comments (
    0
    ) |
Fiber 2-if combination was selected for fiber type, 1st fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 2-if combination was selected for fiber type, 2nd fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 2- dose 1 (g) 4.0
  • Comments Comments (
    0
    ) |
Fiber 2- dose 2 (g) -
  • Comments Comments (
    0
    ) |
Fiber 2-Duration of intervention 2 hours
  • Comments Comments (
    0
    ) |
Fiber 2-how was the fiber administered? Beverage
  • Comments Comments (
    0
    ) |
Fiber 3-type Beta-Glucans
  • Comments Comments (
    0
    ) |
Fiber 3-if combination was selected for fiber type, 1st fiber type in combination High MW -glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
Fiber 3-if combination was selected for fiber type, 2nd fiber type in combination Low MW -glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
Fiber 3- dose 1 (g) 3.0
  • Comments Comments (
    0
    ) |
Fiber 3- dose 2 (g) 1.0
  • Comments Comments (
    0
    ) |
Fiber 3-Duration of intervention 2 hours
  • Comments Comments (
    0
    ) |
Fiber 3-how was the fiber administered? Beverage
  • Comments Comments (
    0
    ) |
Fiber 4-type Beta-Glucans
  • Comments Comments (
    0
    ) |
Fiber 4-if combination was selected for fiber type, 1st fiber type in combination low MW -glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
Fiber 4-if combination was selected for fiber type, 2nd fiber type in combination high MW -glucan, containing 50 g of anhydrous dextrose
  • Comments Comments (
    0
    ) |
Fiber 4- dose 1 (g) 2.0
  • Comments Comments (
    0
    ) |
Fiber 4- dose 2 (g) 2.0
  • Comments Comments (
    0
    ) |
Fiber 4-Duration of intervention 2 hours
  • Comments Comments (
    0
    ) |
Fiber 4-how was the fiber administered? Beverage
  • Comments Comments (
    0
    ) |
Comparator 1- what was the comparator used in the intervention? matched
  • Comments Comments (
    0
    ) |
Comparator 1-dose 0.0
  • Comments Comments (
    0
    ) |
Comparator 1-duration of comparator intervention 2 hours
  • Comments Comments (
    0
    ) |
Comparator 1-how was the comparator administered to participants? Beverage
  • Comments Comments (
    0
    ) |
Comparator 2- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 2-dose -
  • Comments Comments (
    0
    ) |
Comparator 2-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 2-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |
Comparator 3- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 3-dose -
  • Comments Comments (
    0
    ) |
Comparator 3-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 3-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |
Comparator 4- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 4-dose -
  • Comments Comments (
    0
    ) |
Comparator 4-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 4-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.